We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-1.32%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$493M
AUM Growth
-$43.7M
(-8.1%)
Cap. Flow
-$6.65M
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
14.21%
Holding
1,115
New
370
Increased
135
Reduced
155
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.8M |
| 2 |
Micron Technology
MU
|
+$9.79M |
| 3 |
Medtronic
MDT
|
+$7.24M |
| 4 |
Meta Platforms (Facebook)
META
|
+$6.64M |
| 5 |
Alibaba
BABA
|
+$5.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Truist Financial
TFC
|
+$6.76M |
| 2 |
Qualcomm
QCOM
|
+$6.11M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.04M |
| 4 |
EOG Resources
EOG
|
+$4.02M |
| 5 |
T-Mobile US
TMUS
|
+$3.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 13.66% |
| 3 | Consumer Discretionary | 12.3% |
| 4 | Industrials | 9.83% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Sabra Healthcare REIT
SBRA
$5.61B
| $224K | 0.05% |
+17,100
| New | +$253K |
|
502
Alaska Air
ALK
$5.48B
| $222K | 0.05% |
5,661
-5,300
| -48% | -$233K |
|
503
Celldex Therapeutics
CLDX
$2.76B
| $222K | 0.05% |
7,911
-4,589
| -37% | -$141K |
|
504
Bilibili
BILI
$7.56B
| $221K | 0.04% |
14,416
-2,300
| -14% | -$52.4K |
|
505
Crane NXT
CXT
$3.13B
| $221K | 0.04% |
+7,261
| New | +$239K |
|
506
ONE Gas
OGS
$5.12B
| $221K | 0.04% |
+3,144
| New | +$253K |
|
507
IPG Photonics
IPGP
$3.54B
| $219K | 0.04% |
2,600
-7,300
| -74% | -$693K |
|
508
Smith & Wesson
SWBI
$668M
| $218K | 0.04% |
21,056
-11,744
| -36% | -$155K |
|
509
PMV Pharmaceuticals
PMVP
$60.3M
| $217K | 0.04% |
18,200
+1,000
| +6% | +$14.4K |
|
510
M&T Bank
MTB
$36.5B
| $216K | 0.04% |
+1,223
| New | +$216K |
|
511
UFP Industries
UFPI
$5.17B
| $216K | 0.04% |
+3,000
| New | +$239K |
|
512
BCE
BCE
$20.3B
| $214K | 0.04% |
+5,100
| New | +$248K |
|
513
Coty
COTY
$2.49B
| $212K | 0.04% |
33,500
-71,800
| -68% | -$543K |
|
514
Appian
APPN
$1.98B
| $210K | 0.04% |
+5,140
| New | +$249K |
|
515
Mativ Holdings
MATV
$481M
| $210K | 0.04% |
+9,511
| New | +$218K |
|
516
Frontline
FRO
$8.66B
| $209K | 0.04% |
+19,100
| New | +$209K |
|
517
Citizens Financial Group
CFG
$30.6B
| $208K | 0.04% |
+6,058
| New | +$224K |
|
518
Monro
MNRO
$537M
| $206K | 0.04% |
+4,742
| New | +$225K |
|
519
Zoetis
ZTS
$32.8B
| $204K | 0.04% |
1,379
-21,821
| -94% | -$3.65M |
|
520
British American Tobacco
BTI
$135B
| $202K | 0.04% |
+5,700
| New | +$228K |
|
521
Enerpac Tool Group
EPAC
$1.9B
| $198K | 0.04% |
+11,124
| New | +$216K |
|
522
Revolution Medicines
RVMD
$39.1B
| $197K | 0.04% |
10,000
-6,601
| -40% | -$145K |
|
523
Remitly
RELY
$4.83B
| $196K | 0.04% |
+17,667
| New | +$184K |
|
|
INFN
524
DELISTED
Infinera Corporation Common Stock
INFN
| $196K | 0.04% |
+40,400
| New | +$221K |
|
525
Abercrombie & Fitch
ANF
$4.57B
| $190K | 0.04% |
+12,206
| New | +$211K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Bayesian Capital Management held 1,115 positions worth $493M, down 8.1% from $537M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bayesian Capital Management's Q3 2022 filing shows 370 new, 135 increased, 155 reduced and 453 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M. The largest sale was Truist Financial, an estimated $6.76M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bayesian Capital Management's largest Q3 2022 buy was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M.
- Bayesian Capital Management added most to Medtronic in Q3 2022, an estimated $7.24M increase.
- Bayesian Capital Management's biggest Q3 2022 reduction was Truist Financial, cutting an estimated $6.76M.
- Bayesian Capital Management fully exited Walgreens Boots Alliance in Q3 2022, selling an estimated $4.04M.
- Bayesian Capital Management's ten largest holdings make up 14% of its $493M portfolio in Q3 2022.
- Bayesian Capital Management opened 370 new positions and closed 453 in Q3 2022.
- Bayesian Capital Management's portfolio value fell 8.1% quarter-over-quarter to $493M.
Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.